Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A new use for intracellular antibody expression: inactivation of human immunodeficiency virus type 1.

Literature DB >> 8356037

A new use for intracellular antibody expression: inactivation of human immunodeficiency virus type 1.

J R Carlson¹.

Abstract

Entities: Species

Mesh：

Substances：

Year: 1993 PMID： 8356037 PMCID： PMC47153 DOI： 10.1073/pnas.90.16.7427

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

× No keyword cloud information.

12 in total

Review 1. Man-made antibodies.

Authors: G Winter; C Milstein
Journal: Nature Date: 1991-01-24 Impact factor: 49.962

2. Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein.

Authors: J R Feramisco; R Clark; G Wong; N Arnheim; R Milley; F McCormick
Journal: Nature Date: 1985 Apr 18-24 Impact factor: 49.962

3. Production of antibodies in transgenic plants.

Authors: A Hiatt; R Cafferkey; K Bowdish
Journal: Nature Date: 1989-11-02 Impact factor: 49.962

4. Yeast expression of a catalytic antibody with chorismate mutase activity.

Authors: K Bowdish; Y Tang; J B Hicks; D Hilvert
Journal: J Biol Chem Date: 1991-06-25 Impact factor: 5.157

5. Single-chain antigen-binding proteins.

Authors: R E Bird; K D Hardman; J W Jacobson; S Johnson; B M Kaufman; S M Lee; T Lee; S H Pope; G S Riordan; M Whitlow
Journal: Science Date: 1988-10-21 Impact factor: 47.728

6. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

Authors: J S Huston; D Levinson; M Mudgett-Hunter; M S Tai; J Novotný; M N Margolies; R J Ridge; R E Bruccoleri; E Haber; R Crea
Journal: Proc Natl Acad Sci U S A Date: 1988-08 Impact factor: 11.205

2. Intracellular interference of tick-borne flavivirus infection by using a single-chain antibody fragment delivered by recombinant Sindbis virus.

Authors: W Jiang; K Venugopal; E A Gould
Journal: J Virol Date: 1995-02 Impact factor: 5.103

3. Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies.

Authors: A M Mhashilkar; J Bagley; S Y Chen; A M Szilvay; D G Helland; W A Marasco
Journal: EMBO J Date: 1995-04-03 Impact factor: 11.598

3 in total

A new use for intracellular antibody expression: inactivation of human immunodeficiency virus type 1.

Review 1. Man-made antibodies.

2. Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein.

3. Production of antibodies in transgenic plants.

4. Yeast expression of a catalytic antibody with chorismate mutase activity.

5. Single-chain antigen-binding proteins.

6. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

7. Molecular tools for inactivating a yeast enzyme in vivo.

8. Synthesis and self-assembly of a functional monoclonal antibody in transgenic Nicotiana tabacum.

9. Expression and targeting of intracellular antibodies in mammalian cells.

10. A new means of inducibly inactivating a cellular protein.

1. Interference of coronavirus infection by expression of immunoglobulin G (IgG) or IgA virus-neutralizing antibodies.

2. Intracellular interference of tick-borne flavivirus infection by using a single-chain antibody fragment delivered by recombinant Sindbis virus.

3. Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies.